- Title
- P1.07-025 Correlating ISEND and Tumor Mutation Burden (TMB) with Clinical Outcomes of Advanced Non-Small Cell Lung Cancer (ANSCLC) Patients on Nivolumab
- Creators
- W Park - Hematology and Oncology, University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL/USG Lopes - Hematology and Oncology, University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL/USD Kwon - Department of Medicine, Biostatistics and Bioinformatics, University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL/USV Florou - Hematology and Oncology, University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL/USY.K Chae - Developmental Therapeutics Program of the Division of Hematology Oncology, Robert H Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL/USJ Warsch - Radiology, University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL/USA Ishkanian - Radiation Oncology, University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL/USM Jahanzeb - Medical Oncology, University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL/USR Mudad - Hematology and Oncology, University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL/US
- Publication Details
- Journal of thoracic oncology, Vol.12(11), pp.S2005-S2006
- Publisher
- Elsevier Inc
- Academic Unit
- UMMG Department of Public Health Sciences Research; UMMG Dept of Medicine - Hematology/Oncology; Miller School of Medicine
- Language
- English
- Resource Type
- Journal article
- Record Identifier
- 991031598535402976
Journal article
P1.07-025 Correlating ISEND and Tumor Mutation Burden (TMB) with Clinical Outcomes of Advanced Non-Small Cell Lung Cancer (ANSCLC) Patients on Nivolumab
Journal of thoracic oncology, Vol.12(11), pp.S2005-S2006
2017-11
Metrics
9 Record Views